What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives

Despite some remarkable innovations and the advent of novel molecular classifications the prognosis of patients with advanced gastric cancer (GC) remains overall poor and current clinical application of new advances is disappointing. During the last years only Trastuzumab and Ramucirumab have been a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tirino, Giuseppe, Pompella, Luca, Petrillo, Angelica, Laterza, Maria Maddalena, Pappalardo, Annalisa, Caterino, Marianna, Orditura, Michele, Ciardiello, Fortunato, Galizia, Gennaro, De Vita, Ferdinando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165492/
https://www.ncbi.nlm.nih.gov/pubmed/30205505
http://dx.doi.org/10.3390/ijms19092659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165492/
https://www.ncbi.nlm.nih.gov/pubmed/30205505
http://dx.doi.org/10.3390/ijms19092659

Ejemplares similares